A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure.

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Abstract Text:

Clara Lee,Mark R Smith,Charmane I Eastman,

Night shift work is associated with a myriad of health and safety risks. Phase-shifting the circadian clock such that it is more aligned with night work and day sleep is one way to attenuate these risks. However, workers will not be satisfied with complete adaptation to night work if it leaves them misaligned during days off. Therefore, the goal of this set of studies is to produce a compromise phase position in which individuals working night shifts delay their circadian clocks to a position that is more compatible with nighttime work and daytime sleep yet is not incompatible with late nighttime sleep on days off. This is the first in the set of studies describing the magnitude of circadian phase delays that occurs on progressively later days within a series of night shifts interspersed with days off. The series will be ended on various days in order to take a "snapshot" of circadian phase. In this set of studies, subjects sleep from 23:00 to 7:00 h for three weeks. Following this baseline period, there is a series of night shifts (23:00 to 07:00 h) and days off. Experimental subjects receive five 15 min intermittent bright light pulses (approximately 3500 lux; approximately 1100 microW/cm2) once per hour during the night shifts, wear sunglasses that attenuate all visible wavelengths--especially short wavelengths ("blue-blockers")--while traveling home after the shifts, and sleep in the dark (08:30-15:30 h) after each night shift. Control subjects remain in typical dim room light (<50 lux) throughout the night shift, wear sunglasses that do not attenuate as much light, and sleep whenever they want after the night shifts. Circadian phase is determined from the circadian rhythm of melatonin collected during a dim light phase assessment at the beginning and end of each study. The sleepiest time of day, approximated by the body temperature minimum (Tmin), is estimated by adding 7 h to the dim light melatonin onset. In this first study, circadian phase was measured after two night shifts and day sleep periods. The Tmin of the experimental subjects (n=11) was 04:24+/-0.8 h (mean+/-SD) at baseline and 7:36+/-1.4 h after the night shifts. Thus, after two night shifts, the Tmin had not yet delayed into the daytime sleep period, which began at 08:30 h. The Tmin of the control subjects (n=12) was 04:00+/-1.2 h at baseline and drifted to 4:36+/-1.4 h after the night shifts. Thus, two night shifts with a practical pattern of intermittent bright light, the wearing of sunglasses on the way home from night shifts, and a regular sleep period early in the daytime, phase delayed the circadian clock toward the desired compromise phase position for permanent night shift workers. Additional night shifts with bright light pulses and daytime sleep in the dark are expected to displace the sleepiest time of day into the daytime sleep period, improving both nighttime alertness and daytime sleep but not precluding adequate sleep on days off.

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Publishing Authors By Initials

C Lee,MR Smith,CI Eastman,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Chronobiology international

VOLUME: 23

Page Numbers: 859-75

Journal Abbreviation:

ISSN: 0742-0528

DAY: 3

MONTH: 12

YEAR: 2006

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8501362

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure.

AFFILIATION: Biological Rhythms Research Laboratory, Rush University Medical Center, Chicago, Illinois 60612, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Chronobiol Int

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure Related Publications

• A compromise phase position for permanent night shift workers: circadian phase after two night shifts with scheduled sleep and light/dark exposure.
• A proposal for the mechanism-of-action of diazoparaquinone natural products.
• A three pulse phase response curve to three milligrams of melatonin in humans.
• Can even minimal news coverage influence consumer health-related behaviour? A case study of iodized salt sales, Australia.
• Changing patterns of bacterial infection.
• DNA damage-induced S phase arrest in human breast cancer depends on Chk1, but G2 arrest can occur independently of Chk1, Chk2 or MAPKAPK2.
• Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest.
• Deoxyribonuclease II in apoptosis and the significance of intracellular acidification.
• Dispatch from Landstuhl.
• Fork it over: the cohesion establishment factor Ctf7p and DNA replication.
• Further observations on the suppository as a contraceptive.
• Human tau in an ultradian light-dark cycle.
• Infant Mortality in Relation to Month of Birth.
• Information fluency for undergraduate biology majors: applications of inquiry-based learning in a Developmental Biology course.
• Long-loop reflexes in the tranquilized monkey.
• Lumbar ganglionectomy in peripheral arteriosclerosis.
• Modulation of cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 638850).
• Niche differentiation among sulfur-oxidizing bacterial populations in cave waters.
• Nutrition in Relation to Pregnancy and Lactation.
• Obstruction of the common duct by stone.
• Pelvic mensuration; a study in the perpetuation of error.
• Phylogenetic Footprinting Analysis in the Upstream Regulatory Regions of the Drosophila Enhancer of split Genes.
• Problems in the evolution of obstetrics.
• Prolactin and the return of ovulation in breast-feeding women.
• Role of chromosome segregation genes in BRCA1-dependent lethality.
• Studies on the mechanism of action of prekinamycin, a member of the diazoparaquinone family of natural products: evidence for both sp2 radical and orthoquinonemethide intermediates.
• The Future of Emergency Care in the United States Health System: an Institute of Medicine report.
• The plasma proteins--recent biochemical advances.
• The plasma proteins-clinical applications.
• p53-based cancer therapies: Is defective p53 the Achilles heel of the tumor?